Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001

Clinical Therapeutics
Rafia S RasuRajesh Balkrishnan

Abstract

This study evaluated the association between various socioeconomic and clinical factors relating to patients and physicians and the prescribing of medications that have a high abuse potential or are expensive for the treatment of sleep difficulties in a nationally representative sample of outpatient physician visits in the United States. This cross-sectional study used data from the National Ambulatory Medical Care Survey from 1996-2001. Patients aged > or =18 years who received treatment for sleep difficulties in US outpatient settings over this period were included in the study sample. Office visits were considered related to insomnia/sleep difficulties if relevant International Classification of Diseases, Ninth Revision, diagnosis codes were recorded and if insomnia was reported as the reason for the visit or any medication with a primary indication for insomnia was prescribed. Medications associated with dependence and withdrawal symptoms were categorized as having a high abuse potential. Medications were considered expensive if the average wholesale price of 100 tablets was > or =$150 (ie, the 75th percentile of the total cost of all medications prescribed for sleep disorders only). The data were subjected to multivariate ...Continue Reading

References

Jun 1, 1979·Annals of Internal Medicine·J M Eisenberg
Jan 1, 1991·Social Science & Medicine·J A ClarkJ B McKinlay
Oct 1, 1981·Journal of Pharmaceutical Sciences·M DivollR I Shader
Jan 1, 1981·Pharmacology·H R OchsH J Dengler
Apr 1, 1997·Journal of Neurology·M Lader
Oct 27, 1997·The American Journal of Psychiatry·G E Simon, M VonKorff
Oct 13, 1998·Pharmacology, Biochemistry, and Behavior·C R Rush
Oct 20, 1998·Acta Psychiatrica Scandinavica. Supplementum·E Schweizer, K Rickels
Oct 21, 1998·Therapeutic Drug Monitoring·A D Fraser
Nov 24, 1998·Journal of Clinical Pharmacology·C TranN H Shear
Mar 23, 1999·JAMA : the Journal of the American Medical Association·C M MorinD Brink
Apr 30, 1999·Journal of Psychopharmacology·G DarcourtJ Lavoisy
Dec 28, 1999·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·G Hajak
Aug 25, 2000·Pharmacopsychiatry·M SoykaH J Möller
Jan 5, 2002·The American Journal of Psychiatry·Michael T SmithDaniel J Buysse
Jan 18, 2003·Sleep Medicine Reviews·Judy Wagner, Mary L. Wagner
Nov 25, 2003·Clinical Cornerstone·Thomas Roth, Timothy Roehrs
Nov 25, 2003·Clinical Cornerstone·David N Neubauer
Nov 25, 2003·Clinical Cornerstone·Michael T Smith, David N Neubauer
Dec 9, 2003·Depression and Anxiety·Christopher L DrakeThomas Roth
Jan 2, 2004·The American Journal of Psychiatry·Ripu D JindalMichael E Thase

❮ Previous
Next ❯

Citations

Jun 18, 2011·American Journal of Public Health·Mairead Eastin MoloneyCatherine R Zimmer
Jun 2, 2014·Archives of Gerontology and Geriatrics·Megan E PetrovRichard M Allman
Feb 7, 2009·Current Medical Research and Opinion·Rajesh BalkrishnanMark J Cziraky
Jun 12, 2013·PloS One·Muhammad Junaid PatelAyesha L Sorathia
Jul 28, 2016·Journal of Managed Care & Specialty Pharmacy·Stephen JungNancy E Gibbs
Mar 16, 2007·Journal of General Internal Medicine·Allan H GorollLaurence B Gardner
Oct 20, 2012·Archives of Sexual Behavior·Jose R Agustina, Esperanza L Gómez-Durán
Feb 6, 2014·Sleep·Suzanne M BertischCatherine Buettner
Mar 27, 2015·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Naveed-Ur-Rehman SiddiquiAnwarul Haque
Aug 11, 2018·BMC Health Services Research·Lisa M Kalisch EllettElizabeth E Roughead
Jun 29, 2011·Cadernos de saúde pública·Karleyla Fassarela FirminoSérgia Maria Starling Magalhães

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.